BC
XENT

Bridgefront Capital’s Intersect ENT, Inc XENT Stock Holding History

Bridgefront Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,400
Closed -$215K – 982
2020
Q4 		$215K Buy
+9,400
New +$179K 0.07% 488

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bridgefront Capital's XENT Position: Q1 2021 in Review

Bridgefront Capital sold out of Intersect ENT, Inc (XENT) in Q1 2021, closing a stake of 9,400 shares — an estimated $215K sold.

Bridgefront Capital first reported a position in XENT in Q4 2020 and held it in 1 quarter. The position peaked at $215K in Q4 2020. 108 funds tracked by Wall St. Rank hold XENT as of Q1 2021.

  • Bridgefront Capital reported no remaining Intersect ENT, Inc position as of Q1 2021 after selling out during the quarter.
  • Bridgefront Capital sold 9,400 Intersect ENT, Inc shares in Q1 2021, an estimated $215K.
  • Bridgefront Capital first reported a position in Intersect ENT, Inc in Q4 2020 and held it in 1 quarter.
  • Bridgefront Capital's Intersect ENT, Inc position peaked at $215K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2021.

Based on Bridgefront Capital's 13F filing for Q1 2021, filed 17 May 2021.